USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2022 | -308.4 Thousand USD | 13.71% |
2021 | 2.96 Million USD | -125.05% |
2020 | 2.76 Million USD | 1337.92% |
2019 | -246.14 Thousand USD | -116.34% |
2018 | 799.33 Thousand USD | 25.93% |
2017 | 650.16 Thousand USD | -42.9% |
2016 | 1.08 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q1 | -525.31 Thousand USD | -1121.61% |
2022 Q2 | 32.68 Thousand USD | 106.88% |
2022 Q3 | 64.32 Thousand USD | 96.82% |
2022 Q4 | 51.42 Thousand USD | -20.06% |
2022 Q1 | -474.81 Thousand USD | 16.74% |
2022 FY | - USD | 13.71% |
2021 Q4 | -570.25 Thousand USD | -208.06% |
2021 FY | - USD | -125.05% |
2021 Q3 | -185.11 Thousand USD | 0.0% |
2020 FY | - USD | 1337.92% |
2019 FY | - USD | -116.34% |
2018 FY | - USD | 25.93% |
2017 FY | - USD | -42.9% |
2016 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Babylon Holdings Limited | -176.72 Million USD | 99.825% |
ETAO International Co., Ltd. | -893.88 Million USD | 99.965% |
MedAvail Holdings, Inc. | -41.76 Million USD | 99.262% |
Motus GI Holdings, Inc. | -11.23 Million USD | 97.254% |
ThermoGenesis Holdings, Inc. | -7.74 Million USD | 96.015% |
Titan Medical Inc. | 7.51 Million USD | 104.101% |
UpHealth, Inc. | -16.89 Million USD | 98.175% |